DePuy Synthes
2
3M
1
0.09
1
0.50
1
- Areas of investment
Summary
DePuy Synthes appeared to be the Corporate Investor, which was created in 1999. The venture was found in Europe in Switzerland. The main department of described Corporate Investor is located in the Solothurn.
Among the most popular fund investment industries, there are Wellness, Medical Device. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Innovative Spinal Technologies Besides, a startup needs to be aged 1 and less years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 2 participants. Despite the DePuy Synthes, startups are often financed by Orthofix, Inc, GE Capital. The meaningful sponsors for the fund in investment in the same round are Orthofix, Inc, GE Capital. In the next rounds fund is usually obtained by OrbiMed, MPM Capital, JPMorgan Partners (JPMP).
The fund is generally included in less than 2 deals every year. Deals in the range of 5 - 10 millions dollars are the general things for fund. The increased amount of exits for fund were in 2009. The important activity for fund was in 2003.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.09
- Follow on index
- 0.50
- Investments by industry
- Biotechnology (2)
- Health Care (2)
- Medical Device (2)
- Medical (2)
- Manufacturing (2) Show 1 more
- Investments by region
-
- United States (2)
- Peak activity year
- 2003
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Group Appearance index
- 0.50
- Avg. company exit year
- 7
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Innovative Spinal Technologies | 01 Jan 2003 | Biotechnology, Health Care, Wellness, Manufacturing, Medical Device, Medical | Early Stage Venture | 6M | United States, Massachusetts |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.